These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12079390)

  • 81. Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin.
    Pasquato N; Berni R; Folli C; Alfieri B; Cendron L; Zanotti G
    J Mol Biol; 2007 Feb; 366(3):711-9. PubMed ID: 17196219
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Role of VLDL/chylomicron in amyloid formation in familial amyloidotic polyneuropathy.
    Sun X; Ando Y; Haraoka K; Katsuragi S; Yamashita T; Yamashita S; Okajima M; Terazaki H; Okabe H
    Biochem Biophys Res Commun; 2003 Nov; 311(2):344-50. PubMed ID: 14592420
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Characterization of Non-amyloidogenic G101S Transthyretin.
    Wakita Y; Sato T; Chosa K; Suico MA; Sasaki R; Kawano S; Hashimoto N; Teranishi Y; Imai Y; Morioka H; Shuto T; Kai H
    Biol Pharm Bull; 2018; 41(4):628-636. PubMed ID: 29607936
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy.
    Macedo B; Batista AR; Ferreira N; Almeida MR; Saraiva MJ
    Biochim Biophys Acta; 2008 Sep; 1782(9):517-22. PubMed ID: 18572024
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Impairment of the ubiquitin-proteasome system associated with extracellular transthyretin aggregates in familial amyloidotic polyneuropathy.
    Santos SD; Cardoso I; Magalhães J; Saraiva MJ
    J Pathol; 2007 Oct; 213(2):200-9. PubMed ID: 17724793
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Application to transthyretin analysis].
    Ueda M; Ando Y
    Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The pH-dependent stability of wild-type and mutant transthyretin oligomers.
    Skoulakis S; Goodfellow JM
    Biophys J; 2003 May; 84(5):2795-804. PubMed ID: 12719214
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Thermodynamic Stability and Aggregation Kinetics of EF Helix and EF Loop Variants of Transthyretin.
    Ferguson JA; Sun X; Dyson HJ; Wright PE
    Biochemistry; 2021 Mar; 60(10):756-764. PubMed ID: 33645214
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Serum transthyretin levels in Swedish TTR V30M carriers.
    Buxbaum J; Anan I; Suhr O
    Amyloid; 2010 Jun; 17(2):83-5. PubMed ID: 20462367
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Stability and crystal structures of His88 mutant human transthyretins.
    Yokoyama T; Hanawa Y; Obita T; Mizuguchi M
    FEBS Lett; 2017 Jul; 591(13):1862-1871. PubMed ID: 28563699
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Impairment of autophagy by TTR V30M aggregates: in vivo reversal by TUDCA and curcumin.
    Teixeira CA; Almeida Mdo R; Saraiva MJ
    Clin Sci (Lond); 2016 Sep; 130(18):1665-75. PubMed ID: 27382986
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Oligomeric TTR V30M aggregates compromise cell viability, erythropoietin gene expression and promoter activity in the human hepatoma cell line Hep3B.
    Moreira L; Beirão JM; Beirão I; Pinho e Costa P
    Amyloid; 2015; 22(2):93-9. PubMed ID: 26088020
    [TBL] [Abstract][Full Text] [Related]  

  • 93. TLR2 and 4 signaling pathways are altered in macrophages from V30M TTR mice with down-regulated expression of chemokines.
    Moreira J; Martins H; Saraiva M; Saraiva MJ
    Clin Sci (Lond); 2023 Mar; 137(5):355-366. PubMed ID: 36852978
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Disulfide-bond formation in the transthyretin mutant Y114C prevents amyloid fibril formation in vivo and in vitro.
    Eneqvist T; Olofsson A; Ando Y; Miyakawa T; Katsuragi S; Jass J; Lundgren E; Sauer-Eriksson AE
    Biochemistry; 2002 Nov; 41(44):13143-51. PubMed ID: 12403615
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Dominant cardiac type of familial amyloidotic polyneuropathy associated with a novel transthyretin variant Thr59Arg.
    Obayashi K; Misumi Y; Watanabe T; Ando T; Akagami T; Tasaki M; Shinriki S; Ueda M; Yamashita T; Hirotani S; Ando Y
    Muscle Nerve; 2013 Nov; 48(5):839-41. PubMed ID: 23836350
    [No Abstract]   [Full Text] [Related]  

  • 96. Structure-based analysis of A19D, a variant of transthyretin involved in familial amyloid cardiomyopathy.
    Ferreira P; Sant'Anna R; Varejão N; Lima C; Novis S; Barbosa RV; Caldeira CM; Rumjanek FD; Ventura S; Cruz MW; Foguel D
    PLoS One; 2013; 8(12):e82484. PubMed ID: 24358189
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity.
    Hammarström P; Jiang X; Hurshman AR; Powers ET; Kelly JW
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16427-32. PubMed ID: 12351683
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Efficiency of siRNA for removal of transthyretin V30M in a TTR leptomeningeal animal model.
    Gonçalves P; Martins H; Costelha S; Saraiva MJ
    Amyloid; 2017 Mar; 24(sup1):38-39. PubMed ID: 28434297
    [No Abstract]   [Full Text] [Related]  

  • 99. New structural information and update on liver transplantation in transthyretin-associated amyloidosis. Report from the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders & the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå Sweden, June 1999.
    Ericzon BG; Holmgren G; Lundgren E; Suhr OB
    Amyloid; 2000 Jun; 7(2):145-7. PubMed ID: 10842720
    [No Abstract]   [Full Text] [Related]  

  • 100. Transthyretin slowly exchanges subunits under physiological conditions: A convenient chromatographic method to study subunit exchange in oligomeric proteins.
    Schneider F; Hammarström P; Kelly JW
    Protein Sci; 2001 Aug; 10(8):1606-13. PubMed ID: 11468357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.